Emerging Markets

Join us on the evening of 9 June 2014 when OHE will welcome Professor Anne Mills of the London School of Hygiene and Tropical Medicine who will speak on Universal Health Care: the Holy Grail? Health services available to the whole population free of charge, and providing the best health advice and treatment, was the foundation stone for the creation of the National Health Service.

This research explores which approaches to pricing can produce the greatest efficiency and access to medicines within and across countries.
OHE collaborated on two articles published in the journal Health Economics recently.

OHE was involved in several sessions at the 9th World Congress of the International Heath Economics Association (iHEA). Prof Adrian Towse, OHE’s Director, and Prof Lou Garrison, OHE Visiting Senior Research Fellow for 2012-13 and a professor at the University of Washington, took part in a session focusing on barriers to utilisation and delivery of health service in developing countries.

A new publication from the Office of Health Economics captures the views of thought leaders from around the world about the scientific and economic climate for drug development by 2022. Based on OHE’s 50th anniversary conference, it reflects the perspectives of payers, regulatory and HTA agencies, academia, the non-profit sector and the biopharmaceutical industry.

Measuring and evaluating the impact of development aid is a perennial challenge. Various approaches have been tried. Since many have been aimed at donor needs and objectives, whether or not they adequately reflect improvement in the daily lives of the target population is open to question.

During the last quarter of 2011, OHE team members were involved in discussions and presentations in a range of forums, covering each of OHE's three areas of focus. This post reviews their activities.

This post reviews OHE's activities in September 2011 that contributed to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery of health care, HTA methods and processes, and the economics of the pharmaceutical and life sciences industries.

This is the first in a series of posts that will review OHE’s contributions to advancing thought and stimulating innovative ideas in its three key research areas: financing and delivery of health care, HTA methods and processes, and the economics of the pharmaceutical and life sciences industries.

The August 2011 issue of Health Affairs featured four articles on how and why pricing for pharmaceuticals differs from one country to another. The OHE’s Prof Adrian Towse co-authored the lead article with Prof Patricia Danzon from the Wharton School and Dr Andrew Mulcahy of RAND.

Just published by OHE researchers is a comprehensive analysis of what policy measures are needed to counter the growing global problem of antimicrobial resistance. Their key findings are summarised in this blog post.

Pages

Subscribe to RSS - Emerging Markets